Scope
This focused House summary of the EAU urethral-stricture guideline covers diagnostic work-up, selected male anterior and female stricture pathways, perioperative care and follow-up. Management depends on location, length, degree of obliteration, previous treatment and the patient’s goals. It retains the EAU distinction between strong and weak recommendations and does not replace specialist planning for complex reconstruction.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Establish anatomy and patient priorities
- Assess symptoms, duration, previous treatment and causes such as trauma, instrumentation, surgery, irradiation or urethritis. Document the latest intervention because it affects evaluation and operative timing. Include urinalysis, flow testing, residual urine assessment and appropriate imaging/endoscopy. [1]
- In men undergoing stricture surgery, use validated patient-reported measures for symptoms and quality of life, and a validated sexual-function assessment (strong). Record function before intervention to support meaningful postoperative comparison. [1]
- Perform uroflowmetry and post-void residual measurement for suspected urethral stricture (strong). A prolonged low-flow plateau alone is not a reliable screening diagnosis; interpret it with other findings. [1]
- In men considered for reconstruction, use retrograde urethrography to establish location and length. Combine it with voiding cystourethrography for nearly obliterative strictures, stenoses or pelvic-fracture urethral injury (strong). Cystourethroscopy is an adjunct when further information is needed (weak). [1]
Observation and male endoscopic treatment
- Do not intervene in an incidentally found asymptomatic stricture wider than 16 Fr (weak). The observation recommendation does not apply simply because symptoms are mild in a tighter or otherwise clinically significant stricture. [1]
- DVIU or dilatation is a weakly recommended option for a primary, single, non-obliterative bulbar stricture shorter than 2 cm. Do not use DVIU for penile strictures or DVIU/dilatation alone for segments longer than 2 cm (strong). [1]
- Prefer visually controlled to blind dilatation (weak). Do not perform more than two DVIU/dilatation procedures when urethroplasty is a viable option (strong); repeated endoscopic intervention is not an indefinite substitute for reconstruction. [1]
- If urethroplasty is not viable, intermittent self-dilatation after dilatation/DVIU can stabilize the stricture; adding intraurethral corticosteroid is another weak recommendation. Explain that these strategies tend to stabilize disease rather than make the patient permanently stricture-free. [1]
- Offer paclitaxel-coated balloon dilatation for a recurrent bulbar stricture shorter than 3 cm after at least two previous endoscopic treatments only when the patient is unfit for, or unwilling to undergo, urethroplasty (strong). [1]
- Do not use permanent urethral stents or stents for penile strictures (strong). Temporary stenting after DVIU for recurrent bulbar disease is a weak option only when urethroplasty is not viable. Intralesional injections should remain within clinical trials (weak). [1]
Selected reconstruction decisions
- For penile strictures, offer augmentation urethroplasty using a single-stage or staged approach based on prior procedures and stricture characteristics (strong). Counsel that adverse operative findings may require conversion to a staged procedure. Do not offer anastomotic repair for penile strictures longer than 1 cm because of chordee risk (strong). [1]
- Treat failed hypospadias repair as complex disease and refer to a specialist centre (weak). Offer psychological or psychosexual support for associated dissatisfaction, sexual or urinary dysfunction. Do not use penile skin grafts/flaps when these patients have lichen sclerosus or scarred skin (strong). [1]
- For short traumatic bulbar strictures with nearly complete or complete obliteration and full-thickness spongiofibrosis, use transecting excision and primary anastomosis (strong). For short bulbar strictures unrelated to straddle injury, prefer non-transecting repair or free-graft urethroplasty instead (weak). [1]
- Use free-graft urethroplasty for bulbar strictures not suitable for excision and primary anastomosis (strong). When a graft is needed, buccal or lingual mucosa is a weakly recommended choice if available; discuss oral donor-site complications. Do not use genital skin grafts in lichen sclerosus (strong). [1]
Female urethral stricture
- In women with refractory lower urinary tract symptoms, perform flow rate, residual urine and a voiding cystourethrogram or video-urodynamics (strong). Initial dilatation to 24–41 Fr is a weak recommendation for confirmed female urethral stricture. [1]
- For a first recurrence of female urethral stricture, repeat dilatation with planned weekly self-dilatation using a 16–18 Fr catheter, or planned repeat dilatation, is weakly recommended. For a second recurrence, offer urethroplasty if self-dilatation is not possible or definitive treatment is desired (strong). [1]
Prepare for surgery and remove catheters safely
- Avoid unnecessary catheterisation and ensure staff are trained; avoid non-coated latex catheters (strong). If urinary drainage is the only purpose, avoid catheters larger than 18 Fr (weak). [1]
- After urethral manipulation, allow urethral rest before reconstruction so fibrosis can be assessed. The evidence summary describes at least three months, but inflammation or infection can require longer. Use suprapubic drainage if incapacitating obstruction or retention develops during this period. [1]
- Before urethral surgery, identify and treat urinary infection or colonisation. Give intraoperative antibiotic prophylaxis (strong), chosen with local resistance patterns. Prolonged postoperative prophylaxis through catheter removal has no demonstrated reduction in infectious complications. [1]
- After uncomplicated DVIU or dilatation, remove the catheter within 72 hours (weak). After urethroplasty, perform validated urethrography to assess extravasation before catheter removal (strong); an initial study at seven to ten days can be considered after uncomplicated reconstruction, especially with catheter discomfort (weak). [1]
- After urethroplasty, persistent significant urinary leakage warrants retaining or reinserting the catheter and reassessment after a week. A minor wisp-like leak may permit removal; if its significance is uncertain, keep the catheter for an additional week and repeat assessment. [1]
Detect recurrence and assess function
- Offer follow-up to every patient after urethroplasty and routinely for at least one year (strong). Flexible cystoscopy at three months and a risk-adjusted programme are weak recommendations. Advise patients to seek urological assessment for later recurrent symptoms. [1]
- Assess outcomes beyond freedom from another operation: use patient-reported measures for symptoms/satisfaction and validated sexual-function questionnaires (strong). Cystoscopy or retrograde urethrography can assess anatomical success (weak), including recurrence that has not yet caused symptoms. [1]
Limitations and use
- This selected pathway does not cover every operative technique, posterior/pelvic-fracture stenosis, radiation injury or urethral reconstruction after gender-affirming surgery. Those conditions require their specific specialist sections.
- Length and recurrence thresholds refer to the particular anatomical and clinical groups stated. A weak recommendation reflects greater uncertainty and does not establish one procedure as universally preferable.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Urethral strictures
Selected recommendation material consulted
Publication details
- Issuing organisation
- EAU
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- Europe
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.